Becton, Dickinson and Co. | BDX - Umlaufvermögen

Aktienkurs
152.14
Täglich Wechseln
-2.71 -1.75%
Monatlich
-3.87%
Jährlich
-25.81%
Q2 Prognose
148.88




Umlaufvermögen Veränderung Datum
Abbott USD 26B 1.16B 2025-12
Agilent USD 4.62B 21M 2025-12
Align Technology USD 2.62B 82.47M 2025-12
AngioDynamics USD 161.35M 4.69M 2025-09
Avanos Medical USD 355.4M 4M 2025-12
Baxter International USD 6.87B 61M 2025-12
Becton, Dickinson and Co. USD 9.19B 66M 2025-12
Bio-Rad Laboratories USD 2.91B 64.2M 2025-12
Boston Scientific USD 8.79B 759M 2025-12
Cooper Companies USD 2.13B 27.4M 2025-12
Danaher USD 13.94B 1.18B 2026-03
Dentsply International USD 2.02B 49M 2025-12
Dexcom USD 4.03B 1.19B 2025-12
Edwards Lifesciences USD 6.74B 380M 2025-12
Globus Medical USD 2.13B 201.25M 2025-12
Insulet USD 1.91B 54.6M 2025-12
Integra LifeSciences USD 1.16B 15.96M 2025-12
Intuitive Surgical USD 11.52B 881.5M 2026-03
J&J USD 59.17B 3.55B 2026-03
Masimo USD 926M 122.3M 2025-12
Medtronic USD 24.07B 75M 2025-12
Solventum Corp USD 3.86B 548M 2025-12
Stryker USD 14.76B 1.04B 2025-12
Tandem Diabetes Care USD 618.14M 1.2M 2025-12
Teleflex USD 1.94B 47.65M 2025-12
Terumo JPY 815.56B 71.48B 2025-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Zimmer Biomet Holdings USD 5.12B 715M 2025-12